Vector Labs Ab02553-10.0 Anti-CTGF [HL2198], Human IgG1, kappa (200 μg) Centrifuge Bundle Savings at Sycamore Life Sciences

Description

Product Class: Purified
Clone ID: HL2198
Synonyms: CCN2; HCS24; IGFBP8; IBP-8; IGFBP-8; Connective Tissue Growth factor; CCN family member 2; Cellular communication network factor 2; Hypertrophic chondrocyte-specific protein 24; Insulin-like growth factor-binding protein 8; IGF-binding protein 8
Amount: 200 μg
Application Codes Clone: ELISA
Shipping Temperature: Wet Ice
Buffer Composition: PBS with 0.02% Proclin 300.
Original Format: IgG2c
Storage Temperature: Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.
Chimeric Use Statement: This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2c format, for improved compatibility with existing reagents, assays and techniques.
Specificity Statement: This antibody binds aa 81-94 of hCTGF corresponding to the 2nd domain (Von Willebrand Factor – Type C Repeat). CTGF is a cysteine-rich, matrix-associated, heparin-binding protein. It corss-reacts with similar proteins form the CCN family, such as hCYR1 and hNOV. In vitro, CTGF mediates some of the effects of TGF-beta on skin fibroblasts, such as stimulation of extracellular matrix production, chemotaxis, proliferation and integrin expression. CTGF can promote endothelial cell growth, migration, adhesion and survival and is implicated in endothelial cell function and angiogenesis. CTGF has been implicated in extracellular matrix remodeling in wound healing, scleroderma and other fibrotic processes, as it is capable of up-regulating both matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Thus, CTGF has the potential to activate both the synthesis and degradation of extracellular matrix.
Application Notes: Proteolytically generated fragments of CTGF that retain functionality have been measured in biological fluids; this monoclonal antibody was designed with the intention to: a) discern between cleaved and uncleaved forms on the basis of a loss of immunoreactivity after cleavage (i.e. aa 187-197). This clone bindsaa 81-94 of hCTGF corresponding to the 2nd domain (Von Willebrand Factor – Type C Repeat). b) Develop a sandwich ELISA using two mAbs per fragment, where one mAb is the capture antibody and the other is the detector (together with our non-competitive clones Ab02551 (HL2180) and Ab02552 (HL2181) which recognize distinct regions of CTGF.

Product Class:	Purified
Clone ID:	HL2198
Synonyms:	CCN2; HCS24; IGFBP8; IBP-8; IGFBP-8; Connective Tissue Growth factor; CCN family member 2; Cellular communication network factor 2; Hypertrophic chondrocyte-specific protein 24; Insulin-like growth factor-binding protein 8; IGF-binding protein 8
Amount:	200 μg
Application Codes Clone:	ELISA
Shipping Temperature:	Wet Ice
Buffer Composition:	PBS with 0.02% Proclin 300.
Original Format:	IgG2c
Storage Temperature:	Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.
Chimeric Use Statement:	This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2c format, for improved compatibility with existing reagents, assays and techniques.
Specificity Statement:	This antibody binds aa 81-94 of hCTGF corresponding to the 2nd domain (Von Willebrand Factor – Type C Repeat). CTGF is a cysteine-rich, matrix-associated, heparin-binding protein. It corss-reacts with similar proteins form the CCN family, such as hCYR1 and hNOV. In vitro, CTGF mediates some of the effects of TGF-beta on skin fibroblasts, such as stimulation of extracellular matrix production, chemotaxis, proliferation and integrin expression. CTGF can promote endothelial cell growth, migration, adhesion and survival and is implicated in endothelial cell function and angiogenesis. CTGF has been implicated in extracellular matrix remodeling in wound healing, scleroderma and other fibrotic processes, as it is capable of up-regulating both matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Thus, CTGF has the potential to activate both the synthesis and degradation of extracellular matrix.
Application Notes:	Proteolytically generated fragments of CTGF that retain functionality have been measured in biological fluids; this monoclonal antibody was designed with the intention to: a) discern between cleaved and uncleaved forms on the basis of a loss of immunoreactivity after cleavage (i.e. aa 187-197). This clone bindsaa 81-94 of hCTGF corresponding to the 2nd domain (Von Willebrand Factor – Type C Repeat). b) Develop a sandwich ELISA using two mAbs per fragment, where one mAb is the capture antibody and the other is the detector (together with our non-competitive clones Ab02551 (HL2180) and Ab02552 (HL2181) which recognize distinct regions of CTGF.

Specifications

More Information
Brand	Vector Labs
UNSPSC	12161500

Reviews